Cell Granularity Reflects Immune Cell Function and Enables Selection of Lymphocytes with Superior Attributes for Immunotherapy

© 2023 The Authors. Advanced Science published by Wiley-VCH GmbH..

In keeping with the rule of "form follows function", morphological aspects of a cell can reflect its role. Here, it is shown that the cellular granularity of a lymphocyte, represented by its intrinsic side scatter (SSC), is a potent indicator of its cell state and function. The granularity of a lymphocyte increases from naïve to terminal effector state. High-throughput cell-sorting yields a SSChigh population that can mediate immediate effector functions, and a highly prolific SSClow population that can give rise to the replenishment of the memory pool. CAR-T cells derived from the younger SSClow population possess desirable attributes for immunotherapy, manifested by increased naïve-like cells and stem cell memory (TSCM )-like cells together with a balanced CD4/CD8 ratio, as well as enhanced target-killing in vitro and in vivo. Altogether, lymphocyte segregation based on biophysical properties is an effective approach for label-free selection of cells that share collective functions and can have important applications for cell-based immunotherapies.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Advanced science (Weinheim, Baden-Wurttemberg, Germany) - 10(2023), 28 vom: 02. Okt., Seite e2302175

Sprache:

Englisch

Beteiligte Personen:

Wu, Tongjin [VerfasserIn]
Tan, Joel Heng Loong [VerfasserIn]
Sin, Wei-Xiang [VerfasserIn]
Luah, Yen Hoon [VerfasserIn]
Tan, Sue Yee [VerfasserIn]
Goh, Myra [VerfasserIn]
Birnbaum, Michael E [VerfasserIn]
Chen, Qingfeng [VerfasserIn]
Cheow, Lih Feng [VerfasserIn]

Links:

Volltext

Themen:

Cell granularity
Immunotherapy
Journal Article
Lymphocyte
Research Support, Non-U.S. Gov't
Side scatter
T cells

Anmerkungen:

Date Completed 09.10.2023

Date Revised 18.10.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/advs.202302175

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM360445675